Alexandre Debacker retweeted
Today's webinar, Delivery of Chemically Stabilized RNAi molecules to the Central Nervous System, is now available to view on-demand at your convenience.
Select the link below for access.
oligotherapeutics.org/delive…
#ots #oligonucleotide #oligotherapeutics #science #research
Alexandre Debacker retweeted
Looking forward to @TIDESInforma and hearing the latest on all things oligo and peptide therapeutics. Our Principal Oligo Chemist @AlexandreDebac1 will be there so if you’d like to meet up let us know [email protected]. See you in Vienna
Alexandre Debacker retweeted
Surprise! After local delivery of ASOs to the lung, the most robust gene silencing is seen in fibroblasts. This work led by Minwook Shin is online today at NAR. academic.oup.com/nar/advance… @otsociety Collab @garber_manuel @MaehrLab @KhvorovaL @ESontheimerLab @RTI_UMassChan
New review out: Innovative developments and emerging technologies in RNA therapeutics tandfonline.com/doi/full/10.…
Alexandre Debacker retweeted
I am hiring again - looking for PhD student testing oligonucleotides in GvHD mice. Please spread the word! glassdoor.de/job-listing/phd…
Alexandre Debacker retweeted
REVIEW: Delivery of #Oligonucleotides to the Liver With GalNAc: From Research to Registered Therapeutic Drug
@AlexandreDebac1 @Blakey2David @robertshabib @Alnylam
#oligodelivery @AON_Delivery @RNAVarley @DesaulniersLab
pubmed.ncbi.nlm.nih.gov/3259…
Alexandre Debacker retweeted
Activation of CEBPA in Myeloid Cells by #saRNA in #HCC Patients:
The emergence of an Immunomodulatory Switch for Anti-cancer Therapy
Prof Nagy Habib MD, ChM, FRCS, Imperial College London @imperialcollege @MiNA_Tx #otsmunich
Alexandre Debacker retweeted
OTS is still looking for a volunteer to present a webinar on
"Quantification of oligonucleotides in tissue and distribution"
Please contact @OTSociety or [email protected] if you are interested!
Pic @PHDcomics
Alexandre Debacker retweeted
We are way too excited with our new posters and Actonians beermats which will be popping up in all sorts of places in West London!
If you see one of them, take a photo with it and hit us up on any social media. It might even be good enough to warrant a free pint after training
Alexandre Debacker retweeted
Poster 3586 | 1pm on Tue Apr 2 | Experimental and Molecular Therapeutics – Novel Antitumour Agents 2 | MTL-CEBPA, a drug candidate for hepatocellular carcinoma enhances efficacy of sorafenib #AACR2019
Alexandre Debacker retweeted
Poster 3211 | 8am on Tue Apr 2 | Immunology – Combination Immunotherapies 2 | MTL-CEBPA combined with radiofrequency ablation and immunotherapy enhances immunological anti-tumour responses in an HCC mouse model #AACR2019
Alexandre Debacker retweeted
My first book chapter was just published! You should definitely have a pick at this very comprehensive book on Advances in Nucleic Acids Therapeutics!
pubs.rsc.org/en/content/eboo…
@OTSociety
@RNASociety
@AptamerSociety
@UMassMedRTI
Alexandre Debacker retweeted
Next-generation PNA chimeras exhibit high affinity and potent gene silencing
$IONS $AKCA $WVE $BPTH $RHHBY $GLAXO $AZN
#antisense #gapmer #oligonucleotides #ASO @ionispharma
ncbi.nlm.nih.gov/pubmed/3052…
Alexandre Debacker retweeted
Well done to our @AntonTuranov and to our lab with some impressive breakthroughs on RNAi for Preeclampsia! @UMassMedRTI
nature.com/articles/nbt.4297
Alexandre Debacker retweeted
Julia Alterman @GSBS_UMassMed @UMassMedical student in Anastasia Khvorova's lab presented a webinar for @HDSA on #RNAi-based huntingtin lowering in the central nervous system: a new potential HD therapeutic.
youtube.com/watch?v=_Wi1q-ES…
